BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pathology News
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Tokyo
BEGIN:STANDARD
TZOFFSETFROM:+0900
TZOFFSETTO:+0900
TZNAME:JST
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251117T140000
DTEND;TZID=Europe/London:20251117T150000
DTSTAMP:20260827T195411
CREATED:20251111T142519Z
LAST-MODIFIED:20251111T142519Z
UID:100116750-1763388000-1763391600@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series – Too Many Models\, Too Few Benchmarks: Addressing the benchmarking crisis in AI for pathology
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Professor Jana Lipkova from the University of California\, Irvine\, USA. \nAbstract\nThe field of AI in pathology is experiencing a benchmarking crisis. New models emerge weekly\, each claiming superiority over predecessors\, yet the community lacks rigorous\, reproducible tools to validate these claims. In this talk\, I will present two open benchmarks from our group to address this gap. The first benchmark systematically evaluates state-of-the-art pathology foundation models (FMs) for survival prediction in oncology. We assess model generalization across multiple external cohorts\, compare architectural paradigms (patch- vs. slide-level\, uni- vs. multimodal)\, probe model interpretability and investigate weather FM allow to build pan-cancer generalists model that replace disease-specific models and generalize to rare cancers and conditions not seen during the model training? The second benchmark introduces a framework for safe AI deployment in pathology\, focusing on out-of-distribution (OOD) detection and model “guardrails.” We propose a new taxonomy for OOD scenarios in pathology and a public benchmark that stress-tests existing OOD models across diverse data shifts and real-world variability. Both benchmarks\, including all datasets\, standardized splits\, and evaluation protocols\, are publicly released to serve as standards for model evaluation and comparison\, thereby accelerate further advances and deployment of AI in pathology. \nRegister NowBio\nJana is an Assistant Professor at the University of California\, Irvine\, with joint appointments in the School of Medicine\, School of Biomedical Engineering\, and the School of Computer Science. She completed her postdoctoral fellowship in the AI for Pathology group at Harvard Medical School\, under the mentorship of Dr. Faisal Mahmood. Prior to that\, she earned her Ph.D. in computer-aided medical procedures from the Department of Radiology at the Technical University of Munich. Jana leads the OctoPath Lab (http://octopath.org/)\, which develops AI methods for diagnosis\, prognosis\, and treatment optimization in histopathology and beyond.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-too-many-models-too-few-benchmarks-addressing-the-benchmarking-crisis-in-ai-for-pathology/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/11/TIA-Centre-Seminar-Series-–-Too-Many-Models-Too-Few-Benchmarks-Addressing-the-benchmarking-crisis-in-AI-for-pathology-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251113T160000
DTEND;TZID=Europe/London:20251113T170000
DTSTAMP:20260827T195411
CREATED:20251013T142900Z
LAST-MODIFIED:20251022T123244Z
UID:100116156-1763049600-1763053200@www.pathologynews.com
SUMMARY:Mastering Image Quality Control with AIRA Matrix
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 5 PM CET\, 4 PM GMT\, and 11 AM EST. \nArtificial intelligence is transforming how laboratories and life science organizations approach quality control. This webinar will answer the key question: Why address quality control issues with AI? We’ll explore the benefits of AI-driven solutions\, highlight differentiating features\, and provide a live product demonstration to show how Aira Matrix can improve efficiency and consistency in lab workflows. Attendees will gain practical insights into how AI can help reduce errors\, streamline processes\, and support more reliable outcomes. \nThe session will be led by Marco Comianos\, who heads Aira Matrix’s commercial organization in the United States and Canada. With over 25 years of experience in sales\, marketing\, and commercial leadership across healthcare and life sciences—including roles in medical imaging\, EMR\, and healthcare AI—Marco brings deep expertise in aligning innovative technologies with real-world clinical and research needs. \nLearning Objectives\n\nWhy addressing quality control with AI matters\nHow Aira Matrix differentiates itself in the market\nKey product features and their impact on efficiency\nA live demo of the platform in action\n\nRegister NowPresenter\nMarco Comianos heads Aira Matrix’s commercial organization in the United States and Canada.  He has over 25 years of experience in sales\, marketing and commercial leadership in the Healthcare and Life Sciences industries\, at a broad range of medical imaging\, EMR and healthcare AI companies. He holds a Bachelor of Science Degree in Business Administration
URL:https://www.pathologynews.com/event/mastering-image-quality-control-with-aira-matrix-2/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/AIM-WEB0-Featured-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251111
DTEND;VALUE=DATE:20251116
DTSTAMP:20260827T195411
CREATED:20250625T105457Z
LAST-MODIFIED:20250625T105457Z
UID:100113804-1762819200-1763251199@www.pathologynews.com
SUMMARY:AMP 2025 Annual Meeting & Expo
DESCRIPTION:0000Days00Hrs00Min00SecJoin leading experts in molecular diagnostics at the AMP 2025 Annual Meeting & Expo\, the premier event hosted by the Association for Molecular Pathology. This international gathering offers cutting-edge insights\, hands-on workshops\, and a dynamic expo showcasing the latest innovations in precision medicine and clinical genomics. \nKey topic areas include:\n\nGenetics\nHematopathology\nInfectious Diseases\nInformatics\nSolid Tumors\nTechnical Topics\nEducation & Emerging Areas\n\nWhether you’re advancing laboratory practices\, exploring new technologies\, or shaping the future of molecular medicine\, AMP 2025 is the place to connect\, learn\, and lead. \nRegister Now
URL:https://www.pathologynews.com/event/amp-2025-annual-meeting-expo/
LOCATION:Boston Convention and Exhibition Center\, Boston\, MA\, United States
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/06/AMP-2025-Annual-Meeting-Expo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251110T140000
DTEND;TZID=Europe/London:20251110T150000
DTSTAMP:20260827T195411
CREATED:20251029T090353Z
LAST-MODIFIED:20251029T090353Z
UID:100116469-1762783200-1762786800@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series - Scaling Multiplexed Protein Imaging Analysis for Subcellular-resolution Pathology
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Malte Kuehl from Aarhus University\, Denmark. \nAbstract\nProteins and their spatial distribution constitute the functional foundation of biology\, offering critical insights into health and disease. However\, probing pathological tissues at subcellular resolution remains challenging\, from experimental design through image acquisition to computational analysis. I will present our recent work on Pathology-oriented multiPlexing (PathoPlex) published in Nature\, which introduces key innovations spanning quality control\, experimental design\, and image acquisition\, alongside spatiomic\, a novel software library that accelerates spatial proteomics analysis at the pixel level and beyond. Finally\, I will discuss how these developments\, combined with advances in spatial statistics\, agentic AI\, and collaborative community efforts in open-source software\, offer potential pathways for addressing remaining challenges in spatial proteomics. \nRegister NowBio\nMalte Kuehl studied medicine at the University of Hamburg\, where he joined the Institute of Medical Systems Biology and the III. Medical Department to begin his Doctor of Medicine degree. In 2023\, he joined the Complex Tissue Lab at Aarhus University\, led by Prof. Puelles\, as a postdoc. His primary research interests include spatial omics\, image analysis\, and agentic AI.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-scaling-multiplexed-protein-imaging-analysis-for-subcellular-resolution-pathology/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/10/TIA-Centre-Seminar-Series-–-Scaling-Multiplexed-Protein-Imaging-Analysis-for-Subcellular-resolution-Pathology.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251110
DTEND;VALUE=DATE:20251112
DTSTAMP:20260827T195411
CREATED:20250527T083936Z
LAST-MODIFIED:20250624T130105Z
UID:100112972-1762732800-1762905599@www.pathologynews.com
SUMMARY:3rd Spatial Biology Congress: Asia
DESCRIPTION:0000Days00Hrs00Min00SecGlobal Engage is pleased to announce the 3rd Spatial Biology Congress Asia\, returning to Singapore on 5th and 6th November 2025. This prestigious event continues to serve as a hub for spatial biology experts from academia\, biotech companies\, and the pharmaceutical industry\, coming together to share cutting-edge insights and foster collaborations that push the boundaries of this rapidly evolving field. \nRun as single-track\, over 2-day\, this year’s edition will stage more than 15 top scientists presenting the latest discoveries in using spatial multi-omics tools to uncover molecular insights through the following sessions: \n\nSpatial genomics\, transcriptomics\, proteomics\, metabolomics\, and lipidomics\nComputational & data analysis integration\nSpatial profiling\nImage analysis\, AI and digital pathology for spatial\nSpatial biology in therapeutic areas\nSpatial omics in plant biology\n\nIf you are looking to stay at the forefront of spatial biology\, gain unparalleled insights from leading scientists\, and expand your professional network in this thriving field\, then this meeting is not to be missed. \nRegister NowWhy Attend?\n\n1\nConnect with researchers\, industry leaders\, and potential collaborators from across Asia and beyond. Networking can facilitate partnerships and foster collaborative projects that enhance your team’s research efforts. \n\n\n\n\n2\nGain access to cutting-edge research and developments in spatial biology\, including advancements in imaging technologies\, spatial transcriptomics\, and multi-omics approaches. \n\n\n\n\n3\nLearn from leading experts in the field through keynote presentations\, workshops\, and panel discussions that provide valuable insights into the applications of spatial biology in various research areas. \n\n\n\n\n4\nCross-Disciplinary Perspectives: Engage with professionals from diverse disciplines\, including molecular biology\, pathology\, and bioinformatics\, allowing your team to gain new perspectives and strategies for tackling complex biological questions. \n\n\n\n\n5\nExplore the latest tools and technologies available in the field of spatial biology. Understanding these innovations can help your team stay at the forefront of research and improve experimental outcomes. \n\n\n\n\n6\nStay updated on emerging trends and future directions in spatial biology\, helping your team align research goals with industry needs and advancements.
URL:https://www.pathologynews.com/event/3rd-spatial-biology-congress-asia/
LOCATION:Lee Kong Chian School of Medicine – NTU Singapore (Novena Campus)\, Singapore
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/3rd-Spatial-Biology-Congress-Asia.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251106
DTEND;VALUE=DATE:20251109
DTSTAMP:20260827T195411
CREATED:20251030T083754Z
LAST-MODIFIED:20251030T083754Z
UID:100116503-1762387200-1762646399@www.pathologynews.com
SUMMARY:DP-AI 9.0 2025
DESCRIPTION:0000Days00Hrs00Min00Sec\nFriday Sessions at Google Headquarters\, Chicago\, Illinois\nSaturday Lab Tours at Endeavor Health\, Evanston\, Illinois\n\nThe first day will feature presentations by local and international experts at Google Headquarters in Chicago\, IL. This is a unique opportunity for attendees to learn about Endeavor Health’s innovative approach to integrating digital pathology and AI into their laboratory systems alongside comparative use cases from other hospital systems across North America. \nOn the second day\, attendees will be shuttled to Endeavor Health in Evanston to tour multiple laboratory spaces\, following specimen collection\, processing\, and delivery to pathologist workstations and analysis. \nProgramming Themes:\n1) Institutional/Clinical Practice and Vendor Collaboration\n2) DICOM and its role in DP-AI\n3) Digitization\, Automation\, and DP-AI for building the AP Lab of the Future\n4) The Role of Foundation Models\, Generative AI/LLMs\, and Agentic AI in Pathology\, with a deep dive into the Current State of Regulatory Affairs in DP-AI \nRegister Now
URL:https://www.pathologynews.com/event/dp-ai-9-0-2025/
LOCATION:Google Headquarters\, Chicago\, Chicago\, IL\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/DP-AI-9.0-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251104
DTEND;VALUE=DATE:20251105
DTSTAMP:20260827T195412
CREATED:20251030T082713Z
LAST-MODIFIED:20251030T082713Z
UID:100116487-1762214400-1762300799@www.pathologynews.com
SUMMARY:UKNEQAS CPT Annual Participant Meeting 2025
DESCRIPTION:0000Days00Hrs00Min00SecFuture Innovations and Investments\nLeading The Future by Creating It\nThis event will centre on the future of Cellular Pathology\, exploring innovations\, technological advancements\, and the latest regulatory changes shaping the field. Key discussions will highlight how these developments impact laboratory operations and the workforce. In addition\, breakout sessions and Q&A opportunities with expert coordinators will provide practical insights into addressing everyday challenges faced in the field. \nRegister Now
URL:https://www.pathologynews.com/event/ukneqas-cpt-annual-participant-meeting-2025/
LOCATION:The Parkgate Hotel\, Cardiff\, Westgate Street\, Cardiff\, CF10 1DA\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/UKNEQAS-CPT-Annual-Participant-Meeting-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251104
DTEND;VALUE=DATE:20251105
DTSTAMP:20260827T195412
CREATED:20250513T103255Z
LAST-MODIFIED:20250530T140811Z
UID:100111937-1762214400-1762300799@www.pathologynews.com
SUMMARY:6th NHS Pathology Conference: Improving NHS diagnostics
DESCRIPTION:0000Days00Hrs00Min00SecClinical Diagnostics & Medical Sciences\nCurrent Landscape:\nPathology is increasingly becoming a collaborative and interdisciplinary field\, with a strong focus on integrating innovative technologies and practices. This shift is essential to meet the growing demands of modern healthcare\, where the challenges of disease management\, diagnostics\, and treatment require cutting-edge solutions and cross-border cooperation. \nTimeliness of Event:\nThis conference is especially relevant as healthcare systems face the dual pressures of managing current patient demands and integrating new technologies into pathology services. With the rapid evolution of healthcare needs and the advent of new diagnostic tools\, the event provides a timely platform for discussing how to optimize pathology services across regions and disciplines. \nRegister Now\n\n\n\n\n\n\n\nKey Subjects:\n\nPathology Beyond Borders: Integrating Innovation and Collaboration Across Disciplines: Exploring how international collaboration and innovative approaches are reshaping pathology\, breaking down silos\, and improving global health outcomes.\nMES Procurement Approach: A detailed discussion on the strategies and best practices for procuring Managed Equipment Services (MES)\, ensuring efficient and cost-effective delivery of pathology services.\nFire Panel Discussion: Cross-region Learnings: A dynamic exchange of insights from various regional pathology networks\, focusing on shared challenges and solutions\, operational strategies\, and enhancing cross-region collaboration.\nPathology 2.0: Pioneering Tech Advancements Shaping Future Services: Delving into the latest technological innovations such as AI\, digital pathology\, and next-generation sequencing that are revolutionising pathology services and setting the stage for the future.\nLocal Pathology Networks: Examining the role of local pathology networks in managing demand and capacity\, ensuring quality service delivery\, and optimising resource utilisation.\nManaging Demand and Capacity: Addressing the operational challenges in pathology\, including strategies for efficient demand management and capacity planning to meet the needs of modern healthcare.\n\nWhy Attend:\nAttendees will gain valuable insights into the future of pathology\, with a focus on integrating innovative technologies\, optimising procurement processes\, and enhancing cross-region collaboration. This event is an essential opportunity for professionals to learn from experts\, share best practices\, and explore new approaches to managing the growing complexities of pathology services.
URL:https://www.pathologynews.com/event/6th-nhs-pathology-conference-improving-nhs-diagnostics/
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/Birmingham-2025-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20251028T153000
DTEND;TZID=UTC:20251028T163000
DTSTAMP:20260827T195412
CREATED:20250912T085339Z
LAST-MODIFIED:20250912T085339Z
UID:100115449-1761665400-1761669000@www.pathologynews.com
SUMMARY:ACCESS25 - The Future of Precision Medicine Starts at the Moment of Diagnosis
DESCRIPTION:0000Days00Hrs00Min00SecJoin Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision medicine — access to the right patients\, at the right moment\, with the right data. \nWith the launch of Proscia Aperture™\, biopharma leaders will discover how to automatically identify trial and treatment candidates at the moment of diagnosis—accelerating recruitment and advancing novel therapies. \nClinical lab leaders will learn how Aperture elevates the lab’s strategic role in the precision medicine ecosystem while creating new revenue streams. \nAnd for everyone attending\, the Partner Expo will feature breakthroughs in pathology AI\, next-generation infrastructure\, and enterprise solutions—delivered by the strongest ecosystem in the industry. \nRegister Now
URL:https://www.pathologynews.com/event/access25-the-future-of-precision-medicine-starts-at-the-moment-of-diagnosis/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/09/The-Future-of-Precision-Medicine-Starts-at-the-Moment-of-Diagnosis.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251027T140000
DTEND;TZID=Europe/London:20251027T150000
DTSTAMP:20260827T195412
CREATED:20251014T133819Z
LAST-MODIFIED:20251014T133819Z
UID:100116188-1761573600-1761577200@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series - Conformal Quantification of Predictive Uncertainty in Health AI
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThis seminar features Dr Tapabrata (Rohan) Chakraborty from UCL\, London\, UK. \nAbstract\nFor AI to be trusted for use in high risk applications like healthcare\, it is important to ensure (AI Assurance) that the predictive uncertainty is within guaranteed bounds which can be achieved through conformal prediction based calibration at user defined level of significance. \nRegister NowBio\nRohan is a Theme/Group Lead in Frontier AI Assurance at the Alan Turing Institute and a Principal Research Fellow at UCL Cancer Institute. He leads TRAIL\, the Transparent and Responsible AI Lab shared between UCL/Turing. Rohan is an invited expert in Responsible AI with the Global Partnership on AI and an Editor with Springer Nature Computer Science. Rohan has a PhD in Computer Science and worked as a postdoctoral researcher at the University of Oxford where he continues to an Honorary Fellow of Linacre College and a Lecturer in Computer Science with Christ Church College.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-conformal-quantification-of-predictive-uncertainty-in-health-ai/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/10/TIA-Centre-Seminar-Series-Conformal-Quantification-of-Predictive-Uncertainty-in-Health-AI.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251023T160000
DTEND;TZID=Europe/London:20251023T170000
DTSTAMP:20260827T195412
CREATED:20251019T084830Z
LAST-MODIFIED:20251019T084830Z
UID:100116283-1761235200-1761238800@www.pathologynews.com
SUMMARY:AISight Dx Digital Pathology Platform: Live Deep Dive
DESCRIPTION:0000Days00Hrs00Min00SecJoin PathAI to learn how AISight Dx supports modern pathology workflows at enterprise scale. \nIn this webinar\, PathAI will show how AISight® Dx supports modern digital pathology workflows at scale\, including seamless slide management\, flexible collaboration\, and interoperability across a broad range of whole-slide imaging scanners\, and will explain what PCCP means for ongoing updates and customer value. \nYou’ll also see a live demonstration with case-based examples covering slide navigation\, AISight Live for synchronous and asynchronous collaboration\, annotation tools\, and the caselist dashboard. \nWhat you’ll learn\n\nWhat FDA 510(k) clearance with a PCCP means in practice for AISight Dx and your roadmap\nHow pathologists and lab leaders can standardize workflows\, collaborate across teams\, and stay ready for future feature updates enabled under the PCCP\nLive demo: lightning-fast slide navigation and manipulation\, measurements and annotations\, real-time and asynchronous collaboration with AISight Live\, case list triage\, search\, filters\, and workflow handoffs\n\nRegister Now
URL:https://www.pathologynews.com/event/aisight-dx-digital-pathology-platform-live-deep-dive/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/10/AISight-Dx-Digital-Pathology-Platform-Live-Deep-Dive.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251021T160000
DTEND;TZID=Europe/London:20251021T170000
DTSTAMP:20260827T195412
CREATED:20250827T154822Z
LAST-MODIFIED:20250827T154822Z
UID:100115293-1761062400-1761066000@www.pathologynews.com
SUMMARY:Multi-Omics Analysis Demonstrates Repetitive Head Impacts Induce Neuronal Loss and Neuroinflammation in Young Athletes
DESCRIPTION:0000Days00Hrs00Min00SecLearn how HALO image analysis is helping to advance the understanding of chronic traumatic encephalopathy!\nSummaryRepetitive head impacts (RHI) sustained from contact sports are the largest risk factor for chronic traumatic encephalopathy (CTE). Currently\, CTE can only be diagnosed after death and the multicellular cascade of events that trigger initial hyperphosphorylated tau (p-tau) deposition remain unclear. Further\, the symptoms endorsed by young individuals with early disease are not fully explained by the extent of p-tau deposition\, severely hampering development of therapeutic interventions. Using genomics\, spatial transcriptomics\, and histology it was observed that RHI exposure associates with a multicellular response in young individuals (<51 years old) prior to the onset of CTE p-tau pathology that correlates with number of years of RHI exposure. SPP1+ inflammatory microglia\, angiogenic and inflamed endothelial cell profiles\, reactive astrocytes\, and altered synaptic gene expression in excitatory and inhibitory neurons were identified in all individuals with exposure to RHI. Surprisingly\, elevation in collagen deposition around blood vessels that might be related to long term disease outcomes was also observed. Overall\, these results provide robust evidence that multiple years of RHI exposure is sufficient to induce lasting cellular alterations that may underlie p-tau deposition and help explain the early pathogenesis in young former contact sport athletes. \nLearning Objectives\nUnderstand how HALO image analysis can assist in characterizing pathology in neurodegenerative diseases \nUnderstand how HALO AI can be used to identify unique cell populations with complex\, varied shapes \nExplore how genomic data can be validated using histologic images analysis\n\nRegister NowPresenterJonathan Cherry\, PhD \nResearch Health Scientist \nVA Boston Healthcare System \nDirector\, Digital Pathology Core & Research Neuropathologist \nBoston University Alzheimer’s Disease Research Center and Boston University Chronic Traumatic Encephalopathy Center \nAssistant Professor of Pathology and Laboratory Medicine\nBoston University Avedisian & Chobanian School of Medicine \nDr. Cherry is an Assistant Professor of Pathology and Laboratory Medicine. He completed his undergraduate studies with a BS in biology at Ursinus College in 2008\, earned his doctoral degree in Pathology from the University of Rochester in 2015\, and joined the McKee laboratory as a postdoctoral researcher the same year. He was appointed as an assistant professor at Boston University School of Medicine in 2019. Dr. Cherry also holds a research health scientist position within the VA Boston Healthcare System. His laboratory space is located at the Jamaica Plain VA hospital where he performs his research and helps support the UNITE brain bank.  \nDr. Cherry’s research interests focus on understanding how neuroinflammation after repetitive traumatic brain injury contributes to CTE pathogenesis. Specifically\, Dr. Cherry seeks to identify what role microglia and inflammatory cytokines play in the early onset of hyperphosphorylated tau accumulation and spread.  \nDr. Cherry’s research also extends to histology analysis and machine learning. He is the director of the BU digital pathology core. This research entails exploring novel ways to analyze human postmortem tissue using machine learning algorithms for neuropathologic targets and better characterize pathology across a spectrum of neurodegenerative diseases including Alzheimer’s disease\, chronic traumatic encephalopathy\, frontotemporal lobar degeneration\, motor neuron diseases\, and others. 
URL:https://www.pathologynews.com/event/multi-omics-analysis-demonstrates-repetitive-head-impacts-induce-neuronal-loss-and-neuroinflammation-in-young-athletes/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/Multi-Omics-Analysis-Demonstrates-Repetitive-Head-Impacts-Induce-Neuronal-Loss-and-Neuroinflammation-in-Young-Athletes.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251020
DTEND;VALUE=DATE:20251022
DTSTAMP:20260827T195412
CREATED:20250624T132630Z
LAST-MODIFIED:20250731T142434Z
UID:100113792-1760918400-1761091199@www.pathologynews.com
SUMMARY:Conference on Artificial Intelligence in Medical Imaging
DESCRIPTION:0000Days00Hrs00Min00Sec\n\n\nCMIMI is now SIIM-CAIMI!\n\n\n\n\n\n\nNew name. Sharper focus. Same cutting-edge research.\n\n\n\n\n\nUnparalleled Research Focus\n\n\n\n\n\n\nIn-depth talks from top AI and imaging research centers with live Q&A\nA space to test ideas\, challenge norms\, and refine AI approaches\nAccepted abstracts published in the Supplement to the Journal of Imaging Informatics in Medicine\n\n\n\n\n\n\n\n\nImmersive Scientific Discussions\n\n\n\n\n\n\nDeep dives into methods\, results\, and clinical relevance\nDiscussions on AI bias\, model generalizability\, and regulatory considerations\nCase study-driven conversations connecting theory to real-world impact\n\n\n\n\n\n\n\n\n\n\nA Multidisciplinary Community\n\n\n\n\n\n\nConnect with researchers\, clinicians\, and industry leaders in an intimate setting\nBuild partnerships across academia and industry\nBe part of a welcoming environment for trainees and early-career professionals\n\n\n\n\n\n\n\n\n\n\n\n\nAI in Action – From Research to Real-World Applications\n\n\n\n\n\n\nCutting-edge model development for accuracy and explainability\nReal-world AI integration in imaging workflows\nEthics and regulation for responsible AI deployment\n\n\n\n\n\n\n\n\nRegister Now
URL:https://www.pathologynews.com/event/conference-on-artificial-intelligence-in-medical-imaging/
LOCATION:University of California\, Irvine\, CA\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/06/Conference-on-Artificial-Intelligence-in-Medical-Imaging.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251017
DTEND;VALUE=DATE:20251022
DTSTAMP:20260827T195412
CREATED:20250710T100115Z
LAST-MODIFIED:20250731T142312Z
UID:100114263-1760659200-1761091199@www.pathologynews.com
SUMMARY:ESMO Congress 2025
DESCRIPTION:0000Days00Hrs00Min00SecThe ESMO Congress is a highly influential global oncology platform for clinicians\, researchers\, patient advocates\, journalists and healthcare industry representatives from all over the world.\nESMO 2025 will be a place where groundbreaking discoveries\, cutting-edge treatments and a collaborative approach converge to shape the future of cancer care. \nYou will be able to learn from internationally renowned experts\, engage in thought-provoking discussions and connect with fellow oncology professionals that are driving advancements in diagnosis\, treatment and survivorship. \nA comprehensive educational and scientific programme will foster exchange and debate of translational cancer science\, showcase first announcements of potentially practice changing data and stimulate multidisciplinary discussions to improve treatment options for our patients. \nLearning objectives\n\nTo review and be updated on prevention\, screening and early diagnosis of cancer\nTo be updated on the latest breakthroughs in basic science\, translational and clinical cancer research\nTo analyze and understand the clinical perspective of the scientific advances in cancer biology\, diagnostics\, and new treatments\nTo learn the optimal roles of novel diagnostics and treatments for patients with cancer\n\nRegister NowMeet Our Partner\n\n\n\n\nMeet Mindpeak\, a pioneer in AI-powered pathology solutions helping labs accelerate cancer diagnostics with precision and efficiency. \nCatch them at ESMO 2025 — Booth #4010.  \nDiscover how AI is reshaping the future of oncology. \n\n\n\n\n\n\n\n\nAccreditation\nESMO-MORA: The Congress programme will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details . \nDisclaimer\nESMO is a scientific and professional\, non-political and non-religious organisation. ESMO will not accept responsibility for any comments or remarks made during any of our events by session chairs\, invited speakers\, presenters\, members or any other contributor\, formally or informally\, which might cause offence or be perceived as being biased. \nThe experts invited by ESMO as abstract Discussants are selected on an individual basis to provide their own interpretation of the data and are not acting as ESMO spokespersons. \nAll Speakers and Discussants are required to declare their interests\, if any\, and include a Declaration of Interest (DOI) slide at the start of their presentation(s). \nThe ESMO recommendations on the clinical utility of new drugs are only presented in the ESMO Clinical Practice Guidelines and such recommendations represent the only official position of ESMO.
URL:https://www.pathologynews.com/event/esmo-congress-2025/
LOCATION:Messe Berlin\, Messedamm 22\, Berlin\, 14055\, Germany
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/07/ESMO-Congress-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251016T160000
DTEND;TZID=Europe/London:20251016T170000
DTSTAMP:20260827T195412
CREATED:20250827T151754Z
LAST-MODIFIED:20250827T152303Z
UID:100115278-1760630400-1760634000@www.pathologynews.com
SUMMARY:Masterclass Webinar: Admin and Metadata Options in HALO Link
DESCRIPTION:0000Days00Hrs00Min00SecLearn how to maximize the efficiency\, customization\, and data management capabilities of your HALO Link deployments!\nSummaryJoin Indica Labs for this Masterclass Webinar designed for system administrators who want to maximize the efficiency\, customization\, and data management capabilities of their HALO Link deployments. This session will provide an in-depth review of the Admin Dashboard\, highlighting tools for managing users\, groups\, and permissions\, and explore the new Diagnostics Monitor tool for troubleshooting image viewing performance bottlenecks.  \n\nThe webinar will also dive into metadata management\, including how to create custom fields that support better data organization. Whether supporting a large research team or managing multi-site deployments\, this session will equip administrators with practical strategies to tailor HALO Link to their needs\, reduce administrative burden\, and empower users to work more efficiently. \n\nLearning Objectives\nLearn about all the functionality in the current Admin Dashboard in HALO Link \nLearn how the new opt-in Diagnostics Monitor feature (available in HALO Link 4.2) provides information for troubleshooting performance bottlenecks with image viewing \nLearn about tools to manage users\, permissions\, and user groups \nLearn about creating and managing system metadata fields  \n\nRegister NowPresentKat Latimer\nHALO Link Associate Product Manager\nIndica Labs  \nKat Latimer earned a ME in Biomedical Engineering from Colorado State University in 2025 and BS in Biochemistry from the University of New Mexico in 2018. Her graduate studies focused on tissue engineering and the use of biomaterials for wound healing. During her undergraduate studies\, Kat participated in several research opportunities including investigating the role of cellular adhesion proteins in HPV oncogene expression.  In 2020 she joined Indica Labs as a Software Quality Assurance Analyst. In 2021 she transitioned to the Product Management team and has since been promoted to the HALO Link Associate Product Manager role where she works closely with the software developers creating new features to improve the user experience. 
URL:https://www.pathologynews.com/event/masterclass-webinar-admin-and-metadata-options-in-halo-link/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/08/Masterclass-Webinar-Admin-and-Metadata-Options-in-HALO-Link.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20251015T150000
DTEND;TZID=Europe/Paris:20251015T160000
DTSTAMP:20260827T195412
CREATED:20250902T135514Z
LAST-MODIFIED:20251013T141041Z
UID:100115332-1760540400-1760544000@www.pathologynews.com
SUMMARY:Spatially Resolved Transcriptomics and Graph-based Deep Learning Improve Accuracy of Routine CNS Tumor Diagnostics
DESCRIPTION:0000Days00Hrs00Min00SecRegister below! The webinar starts at 3 PM CET\, 2 PM BST\, and 9 AM EST. \nSpatially resolved transcriptomics and graph-based deep learning are transforming how researchers approach and understand central nervous system (CNS) tumors. In this webinar we will deep dive into a publication that highlights how the NePSTA (neuropathology spatial transcriptomic analysis) framework combines advanced RNA sequencing technologies with neural network analyses to uncover detailed gene expression landscapes directly within tissue samples—even in complex or ambiguous cases. By mapping gene activity across individual tumor regions\, these tools reveal previously hidden molecular characteristics\, allow for more granular tissue classification\, and address challenges posed by compromised sample quality. \nLearning Objectives:\n\nUnderstand the challenges of conventional CNS tumor diagnostics and how spatial transcriptomics addresses them.\nLearn the basics of spatially resolved transcriptomics and how graph-based deep learning is applied in neuropathology.\nCompare spatial transcriptomics with traditional molecular techniques such as DNA methylation profiling and next-generation sequencing.\n\nRegister NowSpeaker:\nProf. Felix Sahm \nProf. Dr. Dr. med. Felix Sahm\, MBA is Vice-Chair of the Department of Neuropathology and Head of Molecular Neuropathology \nUniversity of Heidelberg \nAn internationally recognized expert in brain tumor diagnostics\, he has authored over 500 publications\, including landmark studies shaping the WHO classification of CNS tumors. His research focuses on integrating molecular and multi-omic approaches to improve precision diagnostics and patient care.
URL:https://www.pathologynews.com/event/spatially-resolved-transcriptomics-and-graph-based-deep-learning-improve-accuracy-of-routine-cns-tumor-diagnostics/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/09/GEN-WEB0-Featured-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251013T140000
DTEND;TZID=Europe/London:20251013T150000
DTSTAMP:20260827T195412
CREATED:20250929T163601Z
LAST-MODIFIED:20251003T080807Z
UID:100115844-1760364000-1760367600@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series - Towards Multimodal AI for Personalized Cancer Treatment
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThe next seminar will take place on Monday\, 13 October\, from 2–3 p.m. UK time. The Centre is delighted to announce that the session will feature Dr. Nadieh Khalili from Radboud UMC\, The Netherlands\, who will be joining online. \nAbstract\nThe integration of diverse data types—such as histopathology\, radiology\, and omics—offers a powerful opportunity to develop AI models that improve cancer diagnosis and treatment selection. In this talk\, I will present recent efforts from our group in developing and validating multimodal deep learning frameworks that predict treatment-relevant biomarkers directly from routine diagnostic images. I will highlight case studies in bladder and prostate cancer and discuss challenges related to data harmonization\, model generalization\, and clinical translation. \nRegister NowBio\nDr Nadieh Khalili is an Assistant Professor in AI at Radboud UMC\, where she leads research at the intersection of deep learning\, digital pathology\, and multi-modal data integration. Her work focuses on developing clinically meaningful AI tools for cancer diagnosis and treatment response prediction. She has a background in biomedical engineering and previously worked in R&D roles in industry. Dr Khalili is also actively involved in organizing scientific events and is a board member of the European Society of Digital Pathology.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-towards-multimodal-ai-for-personalized-cancer-treatment/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/09/TIA-Centre-Seminar-Series-Towards-Multimodal-AI-for-Personalized-Cancer-Treatment-.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251010
DTEND;VALUE=DATE:20251013
DTSTAMP:20260827T195412
CREATED:20250522T130424Z
LAST-MODIFIED:20250603T132950Z
UID:100112813-1760054400-1760313599@www.pathologynews.com
SUMMARY:2nd Annual Congress of Asian Society of Digital Pathology
DESCRIPTION:0000Days00Hrs00Min00SecPixels to Practice: Advancing Digital Pathology in Asia \nWhat to Expect at ASDP 2025Where Pathology Meets AI: The Future of Diagnostics Begins \nThe Asian Society of Digital Pathology (ASDP) Conference 2025 will serve as a pivotal meeting point for leaders in medicine\, artificial intelligence\, and industry. This event brings together a diverse community of clinicians\, researchers\, technologists\, and decision-makers who are shaping the future of diagnostic practice.— and innovation into impact. \nConference Highlights:\n\nVisionary keynote presentations from internationally recognised pioneers in AI and digital pathology\nGroundbreaking research from leading laboratories and academic institutions\nLive demonstrations showcasing AI tools that are transforming diagnostic workflows\nExpert-led panels addressing regulatory pathways and clinical adoption\nNetworking opportunities with global experts\, innovators\, and healthcare policymakers\n\nWho Should Attend:\nFrom clinicians and computational scientists to regulatory experts and healthcare leaders\, ASDP 2025 offers valuable insights and practical knowledge for anyone driving progress in digital diagnostics. This is where knowledge translates into innovation — and innovation into impact. \nRegister Now
URL:https://www.pathologynews.com/event/2nd-annual-congress-of-asian-society-of-digital-pathology/
LOCATION:JW Marriott Mumbai Sahar\, Mumbai\, India
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/2nd-Annual-Congress-of-Asian-Society-of-Digital-Pathology.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251005
DTEND;VALUE=DATE:20251008
DTSTAMP:20260827T195412
CREATED:20250512T180218Z
LAST-MODIFIED:20250821T092240Z
UID:100111927-1759622400-1759881599@www.pathologynews.com
SUMMARY:Pathology Vision 2025
DESCRIPTION:0000Days00Hrs00Min00SecCONNECT WITH INDUSTRY LEADERS\,\nAND THE FUTURE.\nPathology Visions brings together 800+ experts and peers across the field of digital pathology to address real-world\, practical applications of digital pathology today\, as well as the future of the field through new technologies and developments. \nIf you are a clinician or a researcher\, a technician or a trainee\, PathVisions is the place for you. \nYour industry is changing. Are you keeping up? \nRegister NowLook for SIIM at the Digital Pathology Association (DPA)’s Pathology Visions 2025. \nAttend the SIIM Companion Meeting: The Spectrum of Pathology Resources at SIIM: form Basic Science to Pragmatic Approaches to Pixels on October 5 and/or come to Booth #103 for a demo of our Virtual Hospital SIIMulator (VHS)\, an online sandbox for DICOM\, HL7\, FHIR. \nSIIM Companion Meeting: The Spectrum of Pathology Resources at SIIM: from Basic Science to Pragmatic Approaches to PixelsSun\, Oct 5 \n11:00AM – 12:00PM PT \nSeaport Ballroom \n\nThe Challenges of Digital Pathology Conversion: Transitioning from traditional practices to digital pathology focused around the DICOM standard presents unique challenges\, from system integration to data management. We will discuss these challenges in detail and introduce SIIM’s tools and resources to help pathologists and institutions navigate this conversion. Learn about best practices for overcoming common obstacles\, optimizing workflows\, and ensuring smooth implementation.\nThe Breadth of Research in Pathology Imaging at SIIM: SIIM is at the forefront of imaging informatics research\, including in the field of pathology\, based on successes of imaging standardization in radiology. This segment will explore SIIM’s extensive research efforts that are driving innovation in pathology imaging. We will showcase studies\, collaborations\, and advancements that will shape the future of digital pathology\, with a focus on imaging technologies and their application in diagnostic workflows.\nSIIM’s Commitment to Strategic Technical Leadership and Education in Digital Pathology: As part of our mission to empower imaging professionals\, SIIM can provide strategic leadership and education in digital pathology imaging informatics. This section will highlight our ongoing initiatives to advance technical expertise\, provide training programs\, and support the integration of emerging technologies into pathology practice. Learn how SIIM is paving the way for pathologists.
URL:https://www.pathologynews.com/event/pathology-vision-2025/
LOCATION:Manchester Grand Hyatt\, San Diego\, United States
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/PV-San-Diego-Event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251001T150000
DTEND;TZID=Europe/London:20251001T160000
DTSTAMP:20260827T195412
CREATED:20250822T130516Z
LAST-MODIFIED:20250919T113346Z
UID:100115222-1759330800-1759334400@www.pathologynews.com
SUMMARY:Adapt or Fall Behind: Why the Best Labs Use AI
DESCRIPTION:0000Days00Hrs00Min00SecArtificial intelligence is reshaping the lab landscape—not in the future\, but now. In this webinar\, we’ll explore why adopting AI is no longer optional for modern labs and share real-world insights from clinical leaders who have already taken the leap. Learn how labs in anatomic pathology\, microbiology\, cytology\, and more are using AI to impact their staff and the patients they serve—and the lessons they’ve learned along the way. \nPresenter\n\nDr. Chen is a leader in digital and computational pathology\, holding a medical degree from the Mayo Clinic Alix School of Medicine and a master’s in Global Medicine from USC. She completed her anatomic pathology residency at Brigham and Women’s Hospital and an NIH/NCI postdoctoral fellowship in computational pathology at Harvard Medical School and Mass General Brigham. Before joining Techcyte\, Dr. Chen led digital pathology initiatives at a cancer pharmaceutical company\, driving advancements in AI-powered diagnostics.\n\n\n\nRegister Now
URL:https://www.pathologynews.com/event/adapt-or-fall-behind-why-the-best-labs-use-ai/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/WhatsApp-Image-2025-08-22-at-12.34.19-PM.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250930
DTEND;VALUE=DATE:20251002
DTSTAMP:20260827T195412
CREATED:20250820T090136Z
LAST-MODIFIED:20250820T090136Z
UID:100115156-1759190400-1759363199@www.pathologynews.com
SUMMARY:Precision Medicine: Redefining the Future of Healthcare
DESCRIPTION:0000Days00Hrs00Min00Sec\n\n\n\n\nDelivering Personalized Treatments\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nJoin Biomarkers & Precision Medicine UK\, an immersive event now in its 20th year\, spotlighting the latest trends and tools in biomarker research. This year’s agenda also includes dedicated programmes on Spatial Biology for Precision Medicine and Digital Pathology & AI. The event gathers leading experts from global pharmaceutical companies\, pioneering biotech firms & startups\, and leading academic & healthcare institutions\, all contributing to various therapeutic areas and stages of drug development\, clinical trials\, and precision patient treatments. \n\n\n\n\nWhat is Biomarkers & Precision MedicineTargeted therapies are reframing the outlook for human health creating unprecedented scope for life-changing targeted treatments. \nAre you ready to participate in this shared opportunity? Do you have the knowledge\, strategy\, tools and connections in place? \nPrecision Medicine provides the platform for you to learn\, engage and collaborate across the entire targeted therapy R&D ecosystem — an interdisciplinary community of specialists in pharma\, biotech\, academia and healthcare. \nBiomarkers & Precision Medicine UK\, takes place on September 30-1 October in London\, UK. Running across two full days\, with 16 tracks across three dedicated programmes it’s the must attend event for those involved in bringing next-generation personalized treatments to market \nRegister Now\n\n\n\n\n\n\n\n\n\nWhy attend?\n\n\n\n\n\n\n\n\n\n\n\n\nExpand your knowledge\nLet subject specialists take you further and deeper.\nWith comprehensive learning in oncology\, neuroscience and key complementary areas. \nBuild the partnerships you need\nIdentify\, meet and collaborate with the people your strategy requires.\nStart working with those who share your goals with 200 hours of pre-arranged 1-2-1s. \nJoin the conversation\nMeet like-minded peers\, expand your network and engage in interdisciplinary discussion on the latest thinking and practice. \nSee what’s in the pipeline\nOur events are where innovations land.\nBe at the showcase and meet the people behind technologies to give you the edge. \nUnderstand the competitive landscape\nLearn what others in your field are doing.\nEvaluate their successes (and failures) and set your own benchmarks. \nHarness AI & machine learning\nAI & machine-learning tools will be critical in unlocking growth.\nSee the technology in action and speak to those who can help you implement it.
URL:https://www.pathologynews.com/event/precision-medicine-redefining-the-future-of-healthcare/
LOCATION:QEII Centre\, London\, UK\, London\, United Kingdom
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/Precision-Medicine-Redefining-the-Future-of-Healthcare.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250929T140000
DTEND;TZID=Europe/London:20250929T150000
DTSTAMP:20260827T195412
CREATED:20250827T141747Z
LAST-MODIFIED:20250829T120221Z
UID:100115260-1759154400-1759158000@www.pathologynews.com
SUMMARY:Evaluation of HER2-Low and Ultralow Status of Advanced Breast Carcinomas
DESCRIPTION:0000Days00Hrs00Min00SecJoin this webinar to discover how digital pathology with AI evaluation is a more sensitive method for HER2-low assessment. Dr. Anikó Kovács (Department of Clinical Pathology\, Sahlgrenska University Hospital\, Gothenburg\, Sweden) will present findings from a retrospective study on the HER2-low status of advanced breast carcinomas in core biopsies. \nThe aim of the study was to: \n\ncompare the outcome of HER2 scoring using conventional microscopy\, digital pathology\, and AI.\nassess changes in HER2-low status in core biopsies\, matching operation specimens\, and their distant metastases.\n\nRegister for the webinar to learn more about the findings and how AI can help determine a more accurate HER2-low status\, providing an exact percentage of each HER2 score within seconds with high accuracy. \nWho should join?\n\nPathologists involved in biomarker testing\nOncologists relying on HER2-low status in treatment decisions\nAnyone involved in breast cancer diagnostics or therapeutic decision-making\nAnyone interested in using or developing AI models for image analysis in digital pathology\n\nRegister NowSpeakersAnikó Kovács\, MD\, PhD\nAssociate Professor\, Pathologist\, and Lecturer\nSahlgrenska University Hospital \n\nHas worked in research in Sweden for the past 23 years\nBreast cancer research at the Leicester University in the UK\nResearch background also in Japan (Kitasato University) and Hungary\n\nRute Pedrosa\, PhD\nSenior Field Application Scientist\nAiforia Technologies \n\nHas worked at Aiforia for 2.5 years\nPhD at Erasmus University Rotterdam\, focusing on the pathogenesis of brain metastatic disease
URL:https://www.pathologynews.com/event/evaluation-of-her2-low-and-ultralow-status-of-advanced-breast-carcinomas/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/aiforia-her2-low-webinar-pathologynews.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250928
DTEND;VALUE=DATE:20251001
DTSTAMP:20260827T195412
CREATED:20250512T175350Z
LAST-MODIFIED:20250530T140502Z
UID:100111910-1759017600-1759276799@www.pathologynews.com
SUMMARY:Digital Diagnostic Summit 2025
DESCRIPTION:0000Days00Hrs00Min00Sec\n\n\n\n\n\n\n\nInnovation in Action\n\n\n\n\nMoving the needle from theory to actual\, implemented\, and viable digital pathology \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNestled at the base of the breathtaking Wasatch Mountains in the picturesque Park City\, Utah\, the Digital Diagnostic Summit stands as a beacon for innovation and adoption in digital pathology. Here\, leading experts converge in a unique blend of professional collaboration and unconventional networking that go beyond the conference walls and into immersive experiences. \n\n\n\n\n\n\n\n\nRegister NowExecutive Innovation RoundtableAdam Cole\, MD\nFounder & CSO\, TruCore Pathology Group \nGiovanni Lujan\, MD\nDirector\, Digital and Computational Pathology\, The Ohio State University Wexner Medical Center \nMelissa Alexander\, PhD\, MD\nRegional Medical Director\, AstraZeneca \nJill Stefanelli\nPresident and CEO\, Modella AI \nJonathan Anderson\nNational Director of Laboratory Operations\, Solaris \nMatthew Leavitt\, MD\nFounder\, DDx Foundation \nMichael Martinak\, MBA\, SCT (ASCP)\nExecutive Director Anatomic Pathology\, Quest Diagnostics | AmeriPath | Dermpath Diagnostics \nOrly Ardon\, PhD\, MBA\nDirector of Digital Pathology Operations\, Memorial Sloan Kettering Cancer Center \nWes Bernhardt\nManaging Partner\, OnePath Diagnostics
URL:https://www.pathologynews.com/event/digital-diagnostic-summit-2025/
LOCATION:The St. Regis Deer Valley\, Park City\, United States
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/Lumea-Digital-Summit-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250927
DTEND;VALUE=DATE:20251002
DTSTAMP:20260827T195412
CREATED:20250711T143956Z
LAST-MODIFIED:20250731T142206Z
UID:100114333-1758931200-1759363199@www.pathologynews.com
SUMMARY:The ERS Congress 2025
DESCRIPTION:0000Days00Hrs00Min00SecGet all the latest updates in respiratory medicine and science at the ERS Congress 2025.  \nThis year’s theme is ‘Respiratory health around the globe’. \n\n\n\n\n\n\n\n\n\nThe ERS Congress is the world’s largest and most influential event in respiratory medicine\, bringing together leading clinicians\, researchers\, and healthcare professionals to explore the latest advances in the field. With a rich and diverse programme covering everything from airway diseases and sleep disorders to thoracic oncology and critical care\, the congress offers valuable learning opportunities for professionals at all career stages. \nAttendees can benefit from expert-led symposia\, workshops\, and skills training. The congress also emphasizes patient involvement\, with strong collaboration from the European Lung Foundation. \n\n\n\n\n\n\n\n\nRegister NowMeet our partner
URL:https://www.pathologynews.com/event/the-ers-congress-2025/
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/07/The-ERS-Congress-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250926
DTEND;VALUE=DATE:20251001
DTSTAMP:20260827T195412
CREATED:20250721T144846Z
LAST-MODIFIED:20250731T141923Z
UID:100114520-1758844800-1759276799@www.pathologynews.com
SUMMARY:NSH Histotechnology Convention
DESCRIPTION:0000Days00Hrs00Min00SecExperience 4 days of cutting-edge research\, expert-led workshops\, and hands-on histology training in developing specialties. Explore the largest histology-focused Exhibit Hall in America\, featuring top industry vendors previewing equipment\, supplies\, and services for your lab. And create a network of histology experts that will continue to support you when you return to your lab and help to advance your career. \nWho Should Attend\n\nHistotechs/Cytotechs in Clinical\, Veterinary\, and Research Settings\nPathologists and Pathology Assistants\nLab Supervisors/Managers\nScientists / Investigators / Researchers\nStudents interested in a Histology Career\nSample Management Technicians\nStudy Directors/Monitors\nLab Aids that Assist with Study Set-Ups\nAnyone involved in the collection\, processing\, and evaluation of human and animal tissue samples\n\nRegister Now100+ HOURS OF TRAINING\n\nLearning Labs: hands on trainings that provide the opportunity for attendees to observe and practice skills with lab equipment and reagents \nTopic Roundtables: connect one-on-one with peers over your shared interests in histology \nExpress Talks: 15-minute lectures exploring a troubleshooting tip\, management tool or technique demonstration \nWorkshops: 60-minute lectures with interactive Q&A \nScientific Posters: explore new research and findings from your fellow colleagues and practitioners in the field.
URL:https://www.pathologynews.com/event/nsh-histotechnology-convention/
LOCATION:The Long Beach Convention Center\, Long Beach\, CA\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/07/NSH-Histotechnology-Convention.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250925T170000
DTEND;TZID=Europe/London:20250925T180000
DTSTAMP:20260827T195412
CREATED:20250520T203901Z
LAST-MODIFIED:20250919T113423Z
UID:100112612-1758819600-1758823200@www.pathologynews.com
SUMMARY:Prognostic Risk Profiling from Digitized H&E: a look at new international performances of an AI model for breast cancer
DESCRIPTION:0000Days00Hrs00Min00SecRegister using the link\, available below! \nJoin expert pathologist\, Magali Lacroix-Triki\, and Owkin senior data scientist\, Valentin Guary\, as they present new findings on RlapsRisk® BC\, an innovative AI-driven solution for breast cancer recurrence risk assessment from digital pathology slides. This webinar will showcase comprehensive data comparing RlapsRisk® BC’s performance against traditional clinical scores and established molecular tests. Our panel will discuss how this revolutionary tool helps to enhance prognostic accuracy and has the potential to transform treatment decision-making in breast cancer care. \nAttendees will gain valuable insights into:\n▪ The impact of AI-powered digital pathology solutions for outcome and prognostic prediction\n▪ Latest performance results from ongoing studies\n▪ First comparisons with current testing approaches\n▪ Real-world implementation experiences\n▪ Potential impact on treatment planning and patient care \nRlapsRisk® BC is under development and not for clinical use. It is not FDA cleared or approved in the USA. RlapsRisk® BC is developed within the PortrAIt consortium\, a french consortium financed by the government within the framework of France 2030 and by the European Union – Next Generation EU within the framework of the France Relance Plan. \nRegister Here
URL:https://www.pathologynews.com/event/prognostic-risk-profiling-from-digitized-he-a-look-at-new-international-performances-of-an-ai-model-for-breast-cancer/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/gif:https://www.pathologynews.com/wp-content/uploads/2025/05/Featured-Image-Breast-Cancer-Recurrence-Risk-Assessment-from-Digitized-HE-with-RlapsRisk-BC-a-Clinically-Validated-AI-Prognostic-Solution.gif
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250923
DTEND;VALUE=DATE:20250927
DTSTAMP:20260827T195412
CREATED:20250512T164426Z
LAST-MODIFIED:20250521T153349Z
UID:100111902-1758585600-1758931199@www.pathologynews.com
SUMMARY:BSTP – ESTP Congress
DESCRIPTION:0000Days00Hrs00Min00SecThe 2nd Joint BSTP/ESTP Toxicologic Pathology Congress will be held in Manchester\, UK and will take place from 23rd – 26th of September 2025. \nThe British Society of Toxicologic Pathology (BSTP) and the European Society of Toxicologic Pathology (ESTP) are excited to announce the 2nd Joint BSTP/ESTP Toxicologic Pathology Congress\, titled “Carcinogenicity in the 21st Century: Challenges of New Methodologies\, Strategies\, and Their Impact on Pathologists.” \nRegister NowThe Scientific Organizing Committee\, made up of nationally and internationally recognized experts\, has already started putting together an exciting scientific program after their first meeting in May 2024. The congress will cover key topics like new methodologies for carcinogenicity testing in agrochemicals and pharmaceuticals\, predicting carcinogenic potential early on\, assessing new modality drugs\, understanding the human relevance of findings in carcinogenicity studies\, and risk assessment. Expect a mix of plenary lectures\, original scientific presentations\, interactive case discussions\, and poster sessions. Alongside this\, there’ll be an IATP symposium and an ESTP expert workshop focused on the female reproductive system. A trade exhibition will showcase the latest equipment\, technologies\, and services. For a bit of fun\, don’t miss the welcome reception on 23rd September 2025 and the congress dinner on 25th September.
URL:https://www.pathologynews.com/event/bstp-estp-congress/
LOCATION:Hilton Deansgate Hotel\, Manchester
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/Manchester-2025-.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250923
DTEND;VALUE=DATE:20250928
DTSTAMP:20260827T195412
CREATED:20250522T123404Z
LAST-MODIFIED:20250522T135451Z
UID:100112804-1758585600-1759017599@www.pathologynews.com
SUMMARY:28th International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI 2025)
DESCRIPTION:0000Days00Hrs00Min00SecThe 28th International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI 2025) will take place from Tuesday\, September 23 to Saturday\, September 27\, 2025\, in Daejeon\, Republic of Korea. This marks a significant milestone\, as it will be the first time the MICCAI conference is hosted in Korea. \nThe MICCAI 2025 Organising Committee\, together with the local host team in South Korea\, has been preparing for this event over several years with great care and enthusiasm. Their collective efforts are focused on ensuring that MICCAI 2025 provides an engaging\, inclusive\, and high-quality experience for all attendees. \nAs one of the premier gatherings in the field\, the MICCAI annual conference consistently attracts a global community of leading biomedical scientists\, engineers\, and clinicians working at the forefront of medical imaging and computer-assisted interventions. The conference will feature three days of core scientific content\, including oral presentations\, poster sessions\, and keynote lectures. \nSurrounding the main conference are satellite events — workshops\, tutorials\, and challenges — held on the days before and after the main program. These offer in-depth engagement on specialized topics and are a vital part of the MICCAI experience. Attendees will also benefit from industrial sessions and exhibitions\, providing valuable opportunities for interaction between academia and industry. \nAdditionally\, the Student Board and Women in MICCAI Board will enrich the program through a variety of social and networking events\, ensuring a vibrant and supportive environment for all participants. \nAll members of the MICCAI community are warmly invited to join the conference in Daejeon in 2025. It promises to be a memorable and inspiring event\, bringing together experts from around the world to share knowledge\, foster collaboration\, and shape the future of medical image computing and computer-assisted intervention. \nRegister Now
URL:https://www.pathologynews.com/event/28th-international-conference-on-medical-image-computing-and-computer-assisted-intervention-miccai-2025/
LOCATION:Daejeon Convention Center\, Daejeon\, Korea\, Republic of
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/28th-International-Conference-on-Medical-Image-Computing-and-Computer-Assisted-Intervention.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250922
DTEND;VALUE=DATE:20250927
DTSTAMP:20260827T195412
CREATED:20250820T144323Z
LAST-MODIFIED:20250821T092735Z
UID:100115186-1758499200-1758931199@www.pathologynews.com
SUMMARY:National Imaging Informatics Course - Fall 2025
DESCRIPTION:0000Days00Hrs00Min00SecLearn the fundamentals of Imaging Informatics.\n\n\nNational Imaging Informatics Course (NIIC)\, Borne out of our collaboration with the RSNA + DPA\, NIIC is the first of its kind to delve into comprehensive fundamental principles in today’s real-world ecosystem of imaging informatics. \n\n\n\n\nGet working knowledge fast with SIIM’s National Imaging Informatics Course (NIIC)\n\n\n\n\n\nThe National Imaging Informatics Course (NIIC) is an accelerated\, week-long online experience for imaging informaticists seeking to better leverage their expertise towards a broader\, more holistic engagement within the field. \nBorne out of our collaboration with the RSNA and DPA\, NIIC is the first of its kind to delve into comprehensive fundamental principles in today’s real-world ecosystem of imaging informatics – in order to create enduring engagement and innovation within the field. \nParticipants develop a well more well-rounded understanding of the field\, demystify business cases and become more confident\, effective and valuable in the fast-changing medical and healthcare fields – plus earn up to 20 hours of SIIM IIP Credits doing so! \nIt is the perfect opportunity to introduce non-radiology professionals to the field of imaging informatics\, gain relevant understanding of how medical/healthcare systems work in total and impact how patients are cared for every day. \nThis NIIC Term is made possible by a partnership between the Radiological Society of North America (RSNA)\, the Digital Pathology Association (DPA) and the Society for Imaging Informatics in Medicine (SIIM); and initially funded by a grant from the Association of University Radiologists (AUR)\, this course has been developed by a team of faculty comprised of experts in imaging informatics from around the world. \n\n\n\nRegister Now\n\nImaging Informatics for All\n\nNIIC is open to anyone across the healthcare enterprise seeking to gain a baseline understanding of imaging informatics\, advance cross-functional skillsets and invest in their career goals. \n\nIndividual professionals\nPracticing physicians\nInstitutions\nTrainees at all levels\nFaculty\nIT experts\nIndustry partners\nand more!\n\n\n\n\n\n\nKey Features\n\nNIIC’s specialized curriculum is packed with relevant exercises (and tips) across the imaging informatics spectrum that are essential to modern medicine/healthcare including: \n\nClinical workflow\nHardware/software/networking requirements\nStandards\nPatient-centric radiology\nPACS archives\nBusiness aspects\nHot topics: AI\, mission-learning\, data science\, and 3D printing\n\nThe course is efficiently structured with intellectually stimulating pre-work and well-thought-out agendas plus an ample 3-month window to complete homework assignments.
URL:https://www.pathologynews.com/event/national-imaging-informatics-course-fall-2025/
LOCATION:Online
CATEGORIES:Online Training
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/National-Imaging-Informatics-Course.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250922
DTEND;VALUE=DATE:20250926
DTSTAMP:20260827T195412
CREATED:20250512T163418Z
LAST-MODIFIED:20250728T213032Z
UID:100111882-1758499200-1758844799@www.pathologynews.com
SUMMARY:IBMS Congress 2025
DESCRIPTION:0000Days00Hrs00Min00SecLinking learning to the laboratory \nThe IBMS Congress 2025 is set to be one of the most significant gatherings for biomedical and laboratory professionals\, bringing together experts\, researchers\, and industry leaders to discuss the latest advancements in laboratory medicine\, diagnostics\, and pathology. \nOrganized by the Institute of Biomedical Science (IBMS)\, the congress will offer a comprehensive program featuring cutting-edge research\, keynote presentations\, workshops\, and an extensive exhibition showcasing the latest technologies and solutions in the field. \nIBMS Congress will provide an invaluable platform for knowledge exchange\, professional development\, and networking. Attendees will have the opportunity to engage with leading voices in biomedical science\, explore innovations in digital pathology and AI-driven diagnostics\, and participate in discussions shaping the future of laboratory medicine. Whether you’re looking to expand your expertise\, discover new research\, or connect with industry peers\, IBMS Congress 2025 promises to be an unmissable event for the global biomedical science community. \nRegister Now\nWhether you are a first-time attendee or a long-standing participant\, I am delighted to see our vibrant community come together once again to connect\, collaborate\, and innovate. This year’s Congress promises to be our most comprehensive yet\, offering a wealth of knowledge and inspiration through a diverse range of educational programmes\, cutting edge exhibitions\, and unparalleled networking opportunities. \n\nMeet Our PartnersMeet Source LDPath at Stand 720\nVisit Philips on Stand F1\, \nwhere you can connect with our experts and discover our cutting-edge digital pathology solutions – designed to improve diagnostics and simplify workflows.
URL:https://www.pathologynews.com/event/ibms-congress-2025/
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/IBMS-Birmingham-2025.jpg
END:VEVENT
END:VCALENDAR